China Traditional Chinese Medicine Holdings Co. Limited

SEHK:570 Stock Report

Market Cap: HK$11.4b

China Traditional Chinese Medicine Holdings Future Growth

Future criteria checks 0/6

China Traditional Chinese Medicine Holdings is forecast to grow revenue at 4.8% per annum. EPS is expected to grow by 35.9% per annum.

Key information

n/a

Earnings growth rate

35.9%

EPS growth rate

Pharmaceuticals earnings growth11.1%
Revenue growth rate4.8%
Future return on equity5.9%
Analyst coverage

Low

Last updated14 Nov 2024

Recent future growth updates

Recent updates

China Traditional Chinese Medicine Holdings Co. Limited's (HKG:570) P/E Still Appears To Be Reasonable

Jan 04
China Traditional Chinese Medicine Holdings Co. Limited's (HKG:570) P/E Still Appears To Be Reasonable

Is China Traditional Chinese Medicine Holdings (HKG:570) Using Too Much Debt?

Oct 23
Is China Traditional Chinese Medicine Holdings (HKG:570) Using Too Much Debt?

Calculating The Intrinsic Value Of China Traditional Chinese Medicine Holdings Co. Limited (HKG:570)

Aug 23
Calculating The Intrinsic Value Of China Traditional Chinese Medicine Holdings Co. Limited (HKG:570)

Is China Traditional Chinese Medicine Holdings (HKG:570) Using Too Much Debt?

May 22
Is China Traditional Chinese Medicine Holdings (HKG:570) Using Too Much Debt?

China Traditional Chinese Medicine Holdings Co. Limited (HKG:570) Analysts Are Reducing Their Forecasts For This Year

Dec 08
China Traditional Chinese Medicine Holdings Co. Limited (HKG:570) Analysts Are Reducing Their Forecasts For This Year

These 4 Measures Indicate That China Traditional Chinese Medicine Holdings (HKG:570) Is Using Debt Extensively

Sep 05
These 4 Measures Indicate That China Traditional Chinese Medicine Holdings (HKG:570) Is Using Debt Extensively

China Traditional Chinese Medicine Holdings Co. Limited (HKG:570) Analysts Just Cut Their EPS Forecasts Substantially

Jul 20
China Traditional Chinese Medicine Holdings Co. Limited (HKG:570) Analysts Just Cut Their EPS Forecasts Substantially

Calculating The Fair Value Of China Traditional Chinese Medicine Holdings Co. Limited (HKG:570)

Jul 18
Calculating The Fair Value Of China Traditional Chinese Medicine Holdings Co. Limited (HKG:570)

Here's Why I Think China Traditional Chinese Medicine Holdings (HKG:570) Is An Interesting Stock

Jun 01
Here's Why I Think China Traditional Chinese Medicine Holdings (HKG:570) Is An Interesting Stock

Here's Why China Traditional Chinese Medicine Holdings (HKG:570) Can Manage Its Debt Responsibly

Apr 28
Here's Why China Traditional Chinese Medicine Holdings (HKG:570) Can Manage Its Debt Responsibly

Calculating The Fair Value Of China Traditional Chinese Medicine Holdings Co. Limited (HKG:570)

Feb 14
Calculating The Fair Value Of China Traditional Chinese Medicine Holdings Co. Limited (HKG:570)

Here's Why I Think China Traditional Chinese Medicine Holdings (HKG:570) Is An Interesting Stock

Jan 11
Here's Why I Think China Traditional Chinese Medicine Holdings (HKG:570) Is An Interesting Stock

Here's Why China Traditional Chinese Medicine Holdings (HKG:570) Can Manage Its Debt Responsibly

Dec 05
Here's Why China Traditional Chinese Medicine Holdings (HKG:570) Can Manage Its Debt Responsibly

China Traditional Chinese Medicine Holdings Co. Limited (HKG:570) Shares Could Be 27% Below Their Intrinsic Value Estimate

Oct 29
China Traditional Chinese Medicine Holdings Co. Limited (HKG:570) Shares Could Be 27% Below Their Intrinsic Value Estimate

I Ran A Stock Scan For Earnings Growth And China Traditional Chinese Medicine Holdings (HKG:570) Passed With Ease

Oct 11
I Ran A Stock Scan For Earnings Growth And China Traditional Chinese Medicine Holdings (HKG:570) Passed With Ease

These 4 Measures Indicate That China Traditional Chinese Medicine Holdings (HKG:570) Is Using Debt Reasonably Well

Aug 24
These 4 Measures Indicate That China Traditional Chinese Medicine Holdings (HKG:570) Is Using Debt Reasonably Well

Is Now The Time To Put China Traditional Chinese Medicine Holdings (HKG:570) On Your Watchlist?

Jul 13
Is Now The Time To Put China Traditional Chinese Medicine Holdings (HKG:570) On Your Watchlist?

China Traditional Chinese Medicine Holdings Co. Limited (HKG:570) Shares Could Be 46% Below Their Intrinsic Value Estimate

Jun 25
China Traditional Chinese Medicine Holdings Co. Limited (HKG:570) Shares Could Be 46% Below Their Intrinsic Value Estimate

Does China Traditional Chinese Medicine Holdings (HKG:570) Deserve A Spot On Your Watchlist?

Apr 04
Does China Traditional Chinese Medicine Holdings (HKG:570) Deserve A Spot On Your Watchlist?

Are Investors Undervaluing China Traditional Chinese Medicine Holdings Co. Limited (HKG:570) By 30%?

Mar 15
Are Investors Undervaluing China Traditional Chinese Medicine Holdings Co. Limited (HKG:570) By 30%?

China Traditional Chinese Medicine Holdings Co. Limited's (HKG:570) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

Feb 22
China Traditional Chinese Medicine Holdings Co. Limited's (HKG:570) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

China Traditional Chinese Medicine Holdings (HKG:570) Shareholders Have Enjoyed A 19% Share Price Gain

Feb 01
China Traditional Chinese Medicine Holdings (HKG:570) Shareholders Have Enjoyed A 19% Share Price Gain

What Percentage Of China Traditional Chinese Medicine Holdings Co. Limited (HKG:570) Shares Do Insiders Own?

Dec 18
What Percentage Of China Traditional Chinese Medicine Holdings Co. Limited (HKG:570) Shares Do Insiders Own?

Is China Traditional Chinese Medicine Holdings Co. Limited (HKG:570) Trading At A 33% Discount?

Dec 03
Is China Traditional Chinese Medicine Holdings Co. Limited (HKG:570) Trading At A 33% Discount?

Declining Stock and Decent Financials: Is The Market Wrong About China Traditional Chinese Medicine Holdings Co. Limited (HKG:570)?

Nov 18
Declining Stock and Decent Financials: Is The Market Wrong About China Traditional Chinese Medicine Holdings Co. Limited (HKG:570)?

Earnings and Revenue Growth Forecasts

SEHK:570 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202620,199N/AN/AN/A1
12/31/202518,732N/AN/AN/A1
12/31/202419,5761,484N/A1,3142
6/30/202417,2049171,9082,357N/A
3/31/202417,6631,1011,2941,763N/A
12/31/202318,1221,2856801,169N/A
9/30/202317,9091,107174695N/A
6/30/202317,696930-332222N/A
3/31/202316,000847117657N/A
12/31/202214,3047645661,092N/A
9/30/202215,5601,0915121,119N/A
6/30/202216,8151,4174581,146N/A
3/31/202217,9341,675188971N/A
12/31/202119,0531,933-81796N/A
9/30/202117,6771,8973741,372N/A
6/30/202116,3001,8618291,948N/A
3/31/202115,5531,762-731,088N/A
12/31/202014,8061,663-975228N/A
9/30/202014,4231,562-334723N/A
6/30/202014,0391,4613081,218N/A
3/31/202014,1801,5254771,401N/A
12/31/201914,3211,5886461,585N/A
9/30/201913,5281,5632371,341N/A
6/30/201912,7351,538-1731,097N/A
3/31/201911,9971,488261,144N/A
12/31/201811,2591,4392241,190N/A
9/30/201810,5791,3863261,103N/A
6/30/20189,9001,3324281,016N/A
3/31/20189,1191,251N/A1,126N/A
12/31/20178,3381,170N/A1,236N/A
9/30/20177,7851,123N/A419N/A
6/30/20177,2331,075N/A-397N/A
3/31/20176,8831,021N/A534N/A
12/31/20166,533967N/A1,465N/A
9/30/20166,010880N/A1,248N/A
6/30/20165,487794N/A1,031N/A
3/31/20164,598670N/A775N/A
12/31/20153,709546N/A519N/A
9/30/20153,271509N/AN/AN/A
6/30/20152,833471N/A397N/A
3/31/20152,742444N/A361N/A
12/31/20142,650417N/A325N/A
9/30/20142,384370N/AN/AN/A
6/30/20142,117324N/A176N/A
3/31/20141,756261N/A131N/A
12/31/20131,395198N/A85N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if 570's forecast earnings growth is above the savings rate (2.3%).

Earnings vs Market: Insufficient data to determine if 570's earnings are forecast to grow faster than the Hong Kong market

High Growth Earnings: Insufficient data to determine if 570's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 570's revenue (4.8% per year) is forecast to grow slower than the Hong Kong market (7.8% per year).

High Growth Revenue: 570's revenue (4.8% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 570's Return on Equity is forecast to be low in 3 years time (5.9%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/20 11:40
End of Day Share Price 2024/12/20 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

China Traditional Chinese Medicine Holdings Co. Limited is covered by 25 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Ling ZhangBNP Paribas Securities (Asia)
Yue-Kwong LuiBOCOM International Securities Limited
Helena QiuCCB International Securities Limited